ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disparities"

  • Abstract Number: 0329 • ACR Convergence 2024

    Racial, Ethnic, Sex, and Geographical Diversity in Myositis Clinical Trials: Future Steps for Equitable Representation by the MIHRA Global Equity and Clinical Trial Readiness Cores

    Raisa Silva1, Manuel Carpio Tumba2, Sneha Gupta3, Latika Gupta4, Pedro M Machado5, Julie Paik6, Diana Louden7, Lesley Ann Saketkoo8, Sebastian E. Sattui2 and Didem Saygin9, 1Internal medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3University of Pittsburgh Medical Center McKeesport, Pittsburgh, PA, 4Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom, 5Department of Neuromuscular Diseases and Centre for Rheumatology, University College London, London, United Kingdom, 6Johns Hopkins University, Baltimore, MD, 7University of Washington Libraries, Seattle, WA, 8New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, Louisiana State University and Tulane University Medical Schools, New Orleans, LA, 9Rush University Medical Center, Chicago, IL

    Background/Purpose: The growing number of randomized clinical trials (RCTs) in idiopathic inflammatory myopathies (IIMs) points to a promising future for therapeutics in IIM. Adequate representation…
  • Abstract Number: 1019 • ACR Convergence 2024

    The Impact of Race and Ethnicity and Historical Redlining on Psoriatic Disease Burden

    Brittany Banbury1, Sharon Dowell2, Christopher Jenkins3, Emily Holladay4, Fenglong Xie5, Jingyi Zhang5, Grace Wright6, Jeffrey Curtis7 and Gail Kerr8, 1Mount Sinai Beth Israel, Brooklyn, NY, 2NEA Baptist Memorial Hospital, JONESBORO, AR, 3Medstar Georgetown University Hospital, Washington, DC, 4University of Alabama at Birmingham, Edmond, OK, 5University of Alabama at Birmingham, Birmingham, AL, 6Grace C Wright MD PC, New York, NY, 7University of Alabama at Birmingham, Hoover, AL, 8Washington DC VAMC/Georgetown and Howard Universities, Washington, DC

    Background/Purpose: Previous literature has suggested racial and ethnic variations in the clinical expression of psoriatic disease, with Non-White patients having more extensive skin disease, higher…
  • Abstract Number: 1287 • ACR Convergence 2024

    Development of the Academy for Workforce Advancement to Enrich Rheumatology Diversity

    Eli Miloslavsky1, Greta Sirek2, Mia Chandler3, Renato Ferrandiz4, Grace Wright5, Maura Iversen6, Daniel Solomon2, Jeffrey Katz2, Ellen Gravallese7, Sciaska Ulysse8, Valerie Stone2, Gail Kerr9 and Candace Feldman2, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Boston Children’s Hospital, Boston, MA, 4North Alabama Medical Center, Florence, AL, 5AWIR, New York, NY, 6Johnson & Wales University, Boston, MA, 7Brigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA, 8University of California San Francisco, School of Medicine, San Francisco, CA, 9Washington DC VAMC/Georgetown and Howard Universities, Washington, DC

    Background/Purpose: Workforce diversity enhances scientific inquiry and improves healthcare access and quality of care for minoritized populations. While other medicine subspecialties have increasing numbers of…
  • Abstract Number: 2313 • ACR Convergence 2024

    Race and Ethnicity as Predictors of Diagnostic Delay in Psoriatic Arthritis and Axial Spondyloarthritis

    Christine Loftis1, Liron Caplan2, Joanna Padilla Zepeda3, Nicole Mukooba3, Mayan Caplan3, Meika Fang4, Liya Stolyar5, Jessica Walsh6, Gail Kerr7, Siba Raychaudhuri8, Andreas Reimold9 and Maida Wong10, 1University of Colorado Anschutz School of Medicine, Aurora, CO, 2Univ of Colorado School of Medicine/Rocky Mtn Regional Veterans Affairs Medical Center, Aurora, CO, 3University of Colorado, Aurora, CO, 4Veterans Affairs, Los Angeles, 5Veterans Affairs, Palo Alto, 6Veterans Affairs, Salt Lake City, UT, 7Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 8Veterans Affairs, Sacramento, 9University of Texas Southwestern Medical School, Dallas, 10Veterans Affairs, Long Beach

    Background/Purpose: Studies have suggested a delay between symptom onset and diagnosis for Psoriatic Arthritis (PsA) and axial spondyloarthritis (axSpA).  Factors that influence this delay have…
  • Abstract Number: 0173 • ACR Convergence 2024

    Systemic Lupus Erythematosus Mortality—United States, 2018–2022

    Danielle Dawson1, Kurt Greenlund2 and Kamil Barbour2, 1CDC, Atlanta, GA, 2CDC, Alpharetta, GA

    Background/Purpose: Mortality due to cardiovascular disease, infections, and renal disease is elevated in people with systemic lupus erythematosus (SLE) compared with the general population, but…
  • Abstract Number: 0351 • ACR Convergence 2024

    Empowering Lupus Communities: Evaluating a National Peer Support Program for Lupus Teen, Young Adult Patients and Their Families

    Giselle Rodriguez, LCSW1, Priscilla Calvache1, Lillian Mendez2, Kimberly Cabrera1, Roberta Horton1, Lisa Imundo3 and Jillian Rose-Smith1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Carteret, NJ, 3New York Presbyterian Hospital - Columbia Campus, New York, NY

    Background/Purpose: Research shows that peer support groups effectively provide emotional support, enhance knowledge, & improve coping for chronic illnesses. An evaluation of a bilingual hospital…
  • Abstract Number: 1023 • ACR Convergence 2024

    Factors Associated with Delays in Dispensation and Insurance Denials of Janus Kinase Inhibitors

    Igor Dombrovsky1, Michael George2, Joshua Baker2 and Thomas Riley3, 1Pennsylvania Hospital, Philadephia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Hopsital of the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Access to Janus kinase inhibitors (JAKi) is controlled by insurance carriers through prior authorizations and the use of restricted formularies. We previously showed that…
  • Abstract Number: 1405 • ACR Convergence 2024

    Perceived Healthcare Discrimination Among Individuals with Musculoskeletal Conditions: A Retrospective Cross-Sectional Analysis

    Titilayo Adeniran1, Bertilia Trieu2, Sandra Goldsmith1 and Laura Robbins1, 1Hospital for Special Surgery (HSS), New York, NY, 2Hospital for Special Surgery, New York, NY

    Background/Purpose: Musculoskeletal conditions, including osteoarthritis (OA), osteoporosis (OP), rheumatoid arthritis (RA), and chronic pain, significantly burden individuals' health and well-being. These conditions often lead to…
  • Abstract Number: 2377 • ACR Convergence 2024

    Impact of Neighborhood Area Deprivation Index on Outcomes in Lupus Patients in Bronx, NY

    Anitha Ramu1, Justina Shafik2, Maedeh Ashrafi3, Juliann Allen2, Kiera Brennan1 and Noa Schwartz4, 1Montefiore Medical Center, Bronx, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3Jacobi Medical Center, Bronx, NY, 4Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Studies have demonstrated that socioeconomic status (SES) significantly influences outcomes of patients with SLE.1 Traditionally, tools such as income, education, occupation, and housing have…
  • Abstract Number: 0174 • ACR Convergence 2024

    A Nationwide Analysis of Gender and Racial Disparities in Patients with Systemic Sclerosis and Acute Coronary Syndrome

    Omair Khan1, Kundan Jana2, Azka Naeem2, Syed Mujtaba Baqir2, Marlon Rivera Boadla2, Muhammad Hashim khan2 and Vijay Shetty2, 1Maimonides Medical Center, Council Bluffs, IA, 2Maimonides Medical Center, Brooklyn, NY

    Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune condition characterized by widespread skin fibrosis and/or end-organ damage. Previous studies have reported variable outcomes of the disease…
  • Abstract Number: 0353 • ACR Convergence 2024

    Identifying Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus-Based Approach

    Joy Buie1, Michael Fisher1, Hannah Tlydsley2, Kristen Backor2 and Karen Costenbader3, 1Lupus Foundation of America, Washington, DC, 2Charles River Associates, San Francisco, CA, 3Brigham and Women's Hospital/ Harvard Medical School, Boston, MA

    Background/Purpose: Health disparities among racial and ethnic minoritized individuals living with lupus remain a critical public health concern. Challenges related to healthcare affordability, accessibility, and…
  • Abstract Number: 1025 • ACR Convergence 2024

    Gender Disparities in Disease Impact and Treatment Access for Spondyloarthropathies in Latin America: Insights from a Web Survey

    Sebastián Ibáñez1, María Dominga García1 and Natalia González2, 1Clínica Alemana de Santiago, Santiago, Region Metropolitana, Chile, 2Fundación Espondilitis Chile, Santiago, Region Metropolitana, Chile

    Background/Purpose: Previous studies have shown that female patients with spondyloarthritis (SpA) tend to experience a greater impact on their functionality, especially among women in Latin…
  • Abstract Number: 1873 • ACR Convergence 2024

    Race/Ethnicity and Household Income at the County Level Interacts with the Association of Urbanicity and Lupus Nephritis Mortality

    Snehin Rajkumar1, Eric Yen2 and Ram Singh3, 1UCLA David Geffen School of Medicine, Irvine, CA, 2UCLA, Los Angeles, CA, 3UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: The reasons underlying substantial variation in lupus nephritis (LN) deaths by race/ethnicity remain largely unknown. There are no large population-based studies focused on the…
  • Abstract Number: 2388 • ACR Convergence 2024

    Racial/Ethnic Variation in Multimorbidity Risk and Accrual and Comorbid Conditions Among Patients with Systemic Lupus Erythematosus

    Katrina Williamson1, Herbert Heien2, Maria Stevens2, Cynthia Crowson2, Rozalina McCoy2 and Ali Duarte-Garcia2, 1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have been shown to have increased burden of multimorbidity. Racial disparities in multimorbidity have also been shown repeatedly.…
  • Abstract Number: 0177 • ACR Convergence 2024

    Rural-urban Disparities in the Myocardial Infarction Hospitalizations in People with Systemic Lupus Erythematosus in the US

    Sumanth Chandrupatla1 and Jasvinder Singh2, 1University of Alabama at Birmingham, Birmingham, AL, 2Baylor College of Medicine, Birmingham, AL

    Background/Purpose: To assess whether rural-urban disparities exist in people with SLE for hospitalization with myocardial infarction (MI)Methods: We used the 2016-2019 U.S. National Inpatient Sample…
  • 1
  • 2
  • 3
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology